In a multi-institutional, 10-year study1 of almost half a million dogs in the United States, hip dysplasia was the most commonly identified hip joint condition, comprising 67.4% of all conditions described for that joint. Hip dysplasia is associated with joint pain and loss of joint function.
Sensory innervation of the hip joint in dogs consists of the cranial gluteal, sciatic, femoral, and obturator nerves,2–4 although the contribution of the obturator nerve may be inconsistent.2,4,5 It has been reported6 that the craniolateral area of the hip joint capsule is innervated by articular branches of the cranial gluteal nerve, the caudolateral area is innervated by articular branches of the sciatic nerve, and the ventral area is innervated by articular branches of the femoral nerve and articular branches of the obturator nerve. Articular branches innervate distinct areas of the joint capsule directly or indirectly via periosteal branches from the periarticular muscles covering the acetabulum.7–9 The abundance of sensory nerve endings in the hip joint capsule provides the possibility that interruption of these fibers might eliminate pain in the joint.10
Denervation of the hip joint capsule has been described as a treatment to alleviate pain associated with hip dysplasia and osteoarthritis in dogs.9–17 This technique is based on surgical removal of the periosteum in a semicircular manner, beginning at the craniodorsal margin (as far caudally as possible) of the acetabulum and progressing to the cranioventral margin (ventral aspect of the body of the ilium), thereby transecting the sensory nerve fibers (articular branches) innervating the hip joint.8,12,16,17 Originally, periostectomy was achieved through a limited craniolateral open approach10–14; however, percutaneous techniques involving the use of Steinman pins have also been described.18,a
Denervation has resulted in clinical improvement in > 90% of treated dogs, as determined on the basis of owner assessment and results of observational gait analysis in various studies.12–14,16,19 The quality of evidence yielded by most of these studies is diminished by the retrospective nature of the studies, lack of control subjects, small numbers of dogs in some studies, and subjective nature of the assessments. An additional limitation is that it is unclear whether the reported change in gait following denervation was a beneficial effect of the denervation procedure or a reflection of resolving lameness commonly seen in young dogs with hip dysplasia.
To our knowledge, the effect of denervation of the hip joint on objective gait characteristics has not been described for dogs. Dogs with hip dysplasia of various degrees of severity have been evaluated before and after treatment, but not before and after the onset of lameness. Gait characteristics are difficult to assess in dogs with naturally occurring disease, and a standardized method for induction of hip joint pain could help to determine the effect of denervation on gait and the efficacy of denervation in the treatment of joint pain.
In a recent study20 of healthy dogs, investigators described the development of a novel method for inducing acute synovitis of the hip joint by intra-articular injection of sodium urate crystals. Observational and instrumented gait variables (temporospatial, kinetic, and kinematic) were recorded before and 4, 8, and 24 hours after induction of synovitis. Gait changes were similar to those reported for dogs with hip dysplasia. The inflammatory response after intra-articular injection of sodium urate crystals caused a detectable clinical effect and lameness after 1 to 2 hours, which reached maximal intensity at 4 hours and subsided by 24 hours after injection. That study20 highlighted the objectivity of instrumented gait analysis because it allowed the comparison of gait characteristics at various points.
The objective of the study reported here was to use the aforementioned synovitis induction method and assessment modalities to assess effects on gait characteristics of dogs. The hypotheses tested were that selective percutaneous denervation of the hip joint (defined as minimally invasive denervation) would not result in gait abnormalities and that selective denervation of the hip joint of dogs would abolish joint pain.
This manuscript represents a portion of a thesis submitted by Dr. Hassan to the Department of Surgery, Anesthesiology and Radiology at Cairo University as partial fulfillment of the requirements for a PhD degree.
Supported by the Egyptian Government as part of the Joint Supervision Program between Cairo University and Purdue University.
The authors thank Kris Kazmierczak and Dr. Darryl Dickerson for technical assistance and Drs. Ahmed S. Ahmed and Ashraf A. Shamaa for academic support of the Joint Supervision Program.
Coefficient of variation
Peak vertical force
Lincoln JD, Martinez SA, McCormick DJ, et al. Partial sensory denervation. A treatment for the clinical signs of coxofemoral osteoarthritis (abstr), in Proceedings. 34th Ann Conf Vet Orthop Soc 2007;54.
3/4-inch black LP SAT dots, Velcro USA Inc, Manchester, NH.
Animal Walkway System, Tekscan Inc, South Boston, Mass.
GL2- digital camcorder, Canon Inc, Melville, NY.
Walkway System Software, version 7.0, Tekscan Inc, South Boston, Mass.
MaxTRAQ, Innovision Systems Inc, Columbiaville, Mich.
Microsoft Office Excel 2007, Microsoft Corp, Redmond, Wash.
MATLAB, version 126.96.36.1999 (R2010a), MathWork Inc, Natick, Mass.
Torbutrol, Zoetis Inc, Kalamazoo, Mich.
Propofol, Abbott Laboratories, Abbott Park, Ill.
Isoflurane, Piramal Healthcare Ltd, Andhra Pradesh, India.
Cefazolin, Sandoz Inc, Princeton, NJ.
Positioning board assembly (10-010), BioMedtrix, Boontown, NJ.
Monocryl, Ethicon Inc, West Somerville, NJ.
Hydromorphone HCL 2 mg/mL, Baxter Healthcare Corp, Deerfield, Ill.
Rimadyl 100-mg caplets, Zoetis Inc, Orion Corp, Exton, Pa.
Tramadol, Amneal Pharmaceuticals LLC, Bridgewater, NJ.
Dexdomitor, Orion Corp, Espoo, Finland.
Antisedan, Orion Corp, Espoo, Finland.
Beuthanasia-D Special, Intervet/Schering-Plough Animal Health Corp, Kenilworth, NJ.
SPSS, version 21.0, IBM Corp, Armonk, NY.
1. Johnson JA, Austin C, Breur GJ. Incidence of canine appendicular musculoskeletal disorders in 16 veterinary teaching hospitals from 1980 through 1989. Vet Comp Orthop Traumatol 1994; 7:56–69.
2. Birnbaum K, Prescher A, Hessler S, et al. The sensory innervation of the hip joint—an anatomical study. Surg Radiol Anat 1997; 19:371–375.
4. Schmaedecke A, Ferrigno CRA. Anatomic comparison of the innervation of hip joint in human and dogs. Arch Vet Sci 2008; 3:223–228.
5. Huang CH, Hou SM, Yeh LS. The innervation of the canine hip joint capsule: an anatomical study. Anat Histol Embryol 2013; 42:425–431.
6. Kinzel S, Fasselt R, Prescher A, et al. Sensory innervation of the hip joint capsule in dogs [in German]. Tierarztl Prax Ausg K Kleintiere Hemitiere 1998; 26:330–335.
8. Schmaedecke A, Saut JPE, Ferrigno CRA. A quantitative analysis of the nerve fibers of the acetabular periosteum of dogs. Vet Comp Orthop Traumatol 2008; 21:413–417.
9. Lister SA, Roush JK, Renberg WC, et al. Ground reaction force analysis of unilateral coxofemoral denervation for the treatment of canine hip dysplasia. Vet Comp Orthop Traumatol 2009; 22:137–141.
11. Kinzel S, Kupper W. Surgical technique and clinical experiences with hip joint denervation in the dog. Tierarztl Prax 1997; 27:26–29.
12. Kinzel S, Hein S, von Scheven C, et al. 10 years experience with denervation of the hip joint capsule for treatment of canine hip joint dysplasia and arthrosis. Berl Munch Tierarztl Wochenschr 2002; 115:53–56.
13. Kinzel S, von Scheven C, Buecker A, et al. Clinical evaluation of denervation of the canine hip joint capsule: a retrospective study of 117 dogs. Vet Comp Orthop Traumatol 2002; 1:51–56.
14. Braun D, Lautersack O, Schimke E, et al. Dorsal denervation of the hip joint capsule in dogs. Findings of a long running survey. Kleintierpraxis 2003; 48:211–218.
15. Snelling SR, Wong WT. Denervation of the cranio-dorsal joint capsule in canine hip dysplasia: initial results in a pilot trial. Aust Vet Pract 2004; 34:11–15.
16. Ferrigno CRA, Schmaedecke A, Ferraz VCM. A new surgical approach to acetabular denervation in dogs. Pesqui Vet Bras 2007; 27:61–63.
17. Ferrigno CRA, Schmaedecke A, Oliveira LM, et al. Cranial and dorsal acetabular denervation in treatment of hip dysplasia in dogs: 360 days evaluation of 97 cases. Pesqui Vet Bras 2007; 27:333–340.
18. Selmi AL, Penteado BM, Lins BT. Percutaneous hip denervation for the treatment of canine hip dysplasia. Cienc Rural 2009; 39:460–466.
19. Whiteside DP, Remedios AM, Black SR, et al. Meloxicam and surgical denervation of the coxofemoral joint for the treatment of degenerative osteoarthritis in a Bengal tiger (Panthera tigris tigris). J Zoo Wildl Med 2006; 37:416–419.
20. Hassan EA, Lambrechts NE, Moore GE, et al. Development of a model to induce transient synovitis and lameness in the hip joint of dogs. Am J Vet Res 2015; 76:869–876.
21. Impellizeri JA, Tetrick MA, Muir P. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. J Am Vet Med Assoc 2000; 216:1089–1091.
22. Jaegger G, Marcellin-Little DJ, Levine D. Reliability of goniometry in Labrador Retrievers. Am J Vet Res 2002; 63:979–986.
23. Kim J, Rietdyk S, Breur GJ. Comparison of two-dimensional and three-dimensional systems for kinematic analysis of the sagittal motion of canine hind limbs during walking. Am J Vet Res 2008; 69:1116–1122.
24. Kim J, Kazmierczak KA, Breur GJ. Comparison of temporospatial and kinetic variables of walking in small and large dogs on a pressure-sensing walkway. Am J Vet Res 2011; 72:1171–1177.
25. Herzog W, Nigg BM, Read LJ, et al. Asymmetries in ground reaction force patterns in normal human gait. Med Sci Sports Exerc 1989; 21:110–114.
26. Budsberg SC, Jevens DJ, Brown J, et al. Evaluation of limb symmetry indices, using ground reaction forces in healthy dogs. Am J Vet Res 1993; 54:1569–1574.
27. Linder JE. A simple and reliable method for the silver impregnation of nerves in paraffin sections of soft and mineralized tissues. J Anat 1978; 127:543–551.
28. Smith GK, Karbe GT, Agnello KA, et al. Pathogenesis, diagnosis and control of canine hip dysplasia. In: Tobias KM, Johnston SA, eds. Veterinary surgery small animal. St Louis: Elsevier Saunders, 2012;824–848.
30. Liu W, Maitland ME. The effect of hamstring muscle compensation for anterior laxity in the ACL-deficient knee during gait. J Biomech 2000; 33:871–879.
31. O'Connor BL, Visco DM, Brandt KD, et al. Sensory nerves only temporarily protect the unstable canine knees from joint osteoarthritis. Arthritis Rheum 1993; 36:1154–1163.
33. Riser WH, Rhodes WH, Newton CD. Hip dysplasia: theories of pathogenesis. In: Newton CD, ed. Textbook of small animal orthopedics. Philadelphia: JB Lippincott & Co, 1985;953–980.
34. Barr ARS, Denny HR, Gibbs C. Clinical hip dysplasia in growing dogs: the long-term results of conservative management. J Small Anim Pract 1987; 28:243–252.
35. Collard F, Maitre P, Le Quang T, et al. Canine hip denervation: comparison between clinical outcome and gait analysis. Revue Méd Vét 2010; 161:277–282.
36. Quinn MM, Keuler NS, Lu Y, et al. Evaluation of agreement between numerical rating scales, visual analogue scoring scales, and force plate gait analysis in dogs. Vet Surg 2007; 36:360–367.
37. Waxman AS, Robinson DA, Evans RB, et al. Relationship between objective and subjective assessment of limb function in normal dogs with experimentally induced lameness. Vet Surg 2008; 37:241–246.
38. Torres BT, Punke JP, Fu YC, et al. Comparison of canine stifle kinematic data collected with three different targeting models. Vet Surg 2010; 39:504–512.
39. Hazewinkel HA, van den Brom WE, Theyse LF, et al. Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs. Res Vet Sci 2008; 84:74–79.
40. Voss K, Imhof J, Kaestner S, et al. Force plate gait analysis at the walk and trot in dogs with low-grade hind limb lameness. Vet Comp Orthop Traumatol 2007; 20:299–304.